These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31536382)

  • 1. Neuroendocrine prostate cancer: long noncoding RNAs to treat an incurable cancer - an interview with Dr Francesco Crea.
    Crea F
    Epigenomics; 2019 Oct; 11(13):1461-1462. PubMed ID: 31536382
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
    Crea F; Venalainen E; Ci X; Cheng H; Pikor L; Parolia A; Xue H; Nur Saidy NR; Lin D; Lam W; Collins C; Wang Y
    Epigenomics; 2016 May; 8(5):721-31. PubMed ID: 27096814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.
    Su YJ; Yu J; Huang YQ; Yang J
    Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.
    Takayama K; Inoue S
    Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape of Noncoding RNA in Prostate Cancer.
    Hua JT; Chen S; He HH
    Trends Genet; 2019 Nov; 35(11):840-851. PubMed ID: 31623872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of long non-coding RNA GLIDR in prostate cancer.
    Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
    Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interview: from Down's syndrome to basic epigenetics and back again.
    Lawrence J; Telfer C
    Epigenomics; 2013 Dec; 5(6):611-4. PubMed ID: 24283875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the Long Non-Coding RNA NeSt and FOXCUT in Early Stages of Prostate Cancer Samples as Promising Biomarkers.
    Rostami S; Nabi M; Naghavi P; Mohammadzadeh N; Khalili A
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is HOTAIR really involved in neuroendocrine prostate cancer differentiation?
    Mather RL; Wang Y; Crea F
    Epigenomics; 2018 Oct; 10(10):1259-1261. PubMed ID: 30238772
    [No Abstract]   [Full Text] [Related]  

  • 18. The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay Goel.
    Goel A
    Epigenomics; 2022 Mar; 14(6):345-349. PubMed ID: 35081730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targetable long non-coding RNAs in cancer treatments.
    Chen L; Dzakah EE; Shan G
    Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.